SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 488 filers reported holding SEAGEN INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,605,938 | +5.7% | 7,557 | -3.3% | 0.00% | +50.0% |
| Q2 2023 | $1,518,693 | -73.5% | 7,811 | -72.4% | 0.00% | -77.8% |
| Q1 2023 | $5,733,343 | +30.7% | 28,317 | -17.1% | 0.01% | +28.6% |
| Q4 2022 | $4,387,717 | -35.2% | 34,143 | -31.0% | 0.01% | -41.7% |
| Q3 2022 | $6,773,000 | -41.3% | 49,502 | -24.1% | 0.01% | -33.3% |
| Q2 2022 | $11,533,000 | +23.5% | 65,179 | +0.5% | 0.02% | +38.5% |
| Q1 2022 | $9,341,000 | -30.6% | 64,845 | -25.5% | 0.01% | -27.8% |
| Q4 2021 | $13,452,000 | -6.8% | 87,014 | +2.3% | 0.02% | -10.0% |
| Q3 2021 | $14,437,000 | +13.2% | 85,023 | +5.2% | 0.02% | +11.1% |
| Q2 2021 | $12,756,000 | +28.0% | 80,796 | +12.6% | 0.02% | +20.0% |
| Q1 2021 | $9,967,000 | +235.4% | 71,779 | +323.1% | 0.02% | +150.0% |
| Q4 2020 | $2,972,000 | – | 16,967 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |